cjc-1295 + ipamorelin + aod-9604 IPA Blend for Research AOD 9604 vs CJC 1295:

While this approach can increase total GH output, it adds complexity and may not produce proportionally better results for most users

Tesamorelin delivers a targeted, measurable reduction in deep belly fat that other peptides do not consistently match

IGF-1 LR3 (Long R3 IGF-1, CAS 946870-92-4) is a recombinant 83-amino-acid analogue of insulin-like growth factor 1 with an N-terminal extension and Arg3 substitution, extending plasma half-life and reducing IGFBP binding

The peptide approach maintains natural feedback mechanisms, costs significantly less (approximately 10 to 20 percent of HGH pricing), and avoids the suppression of natural GH production that can occur with exogenous administration

Direct, continuous effects are not well established in humans